Quantification of persister formation of Escherichia coli leveraging electronic cell counting and semi-mechanistic pharmacokinetic/pharmacodynamic modelling.

Seeger, Johanna; Michelet, Robin; Kloft, Charlotte

Seeger, Johanna; Michelet, Robin; Kloft, Charlotte.

Afiliação

Seeger J; Department of Clinical Pharmacy and Biochemistry, Institute of Pharmacy, Freie Universitaet Berlin, Kelchstr. 31, 12169, Berlin, Germany.
Michelet R; Department of Clinical Pharmacy and Biochemistry, Institute of Pharmacy, Freie Universitaet Berlin, Kelchstr. 31, 12169, Berlin, Germany.
Kloft C; Department of Clinical Pharmacy and Biochemistry, Institute of Pharmacy, Freie Universitaet Berlin, Kelchstr. 31, 12169, Berlin, Germany.

J Antimicrob Chemother ; 76(8): 2088-2096, 2021 07 15.

Article em En | MEDLINE | ID: mdl-33997902

Assuntos

Escherichia coli; Levofloxacino; Antibacterianos/farmacologia; Eletrônica; Fluoroquinolonas; Humanos; Levofloxacino/farmacologia; Testes de Sensibilidade Microbiana; Ofloxacino

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Escherichia coli / Levofloxacino Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Escherichia coli / Levofloxacino Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article